Xtant Medical Holdings, Inc.

XTNT · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Market Cap$59,214$134,576$62,096$47,855
- Cash$6,199$5,715$20,298$18,243
+ Debt$35,143$23,559$17,072$16,845
Enterprise Value$88,158$152,420$58,870$46,457
Revenue$117,267$91,303$57,969$55,263
% Growth28.4%57.5%4.9%
Gross Profit$68,216$55,467$32,137$32,490
% Margin58.2%60.8%55.4%58.8%
EBITDA-$7,878$5,075-$5,428-$2,513
% Margin-6.7%5.6%-9.4%-4.5%
Net Income-$16,449$660-$8,485-$4,849
% Margin-14%0.7%-14.6%-8.8%
EPS Diluted-0.120.005-0.09-0.057
% Growth-2,407.7%105.8%-59.1%
Operating Cash Flow-$11,896-$9,515-$5,341$439
Capital Expenditures-$4,113-$1,456-$1,764-$2,115
Free Cash Flow-$16,009-$10,971-$7,105-$1,676